AUG 17, 2026 · JOURNAL ARTICLE
Cardiac monitoring and incidence of cardiotoxicity cardiomyopathy among breast cancer patients undergoing anthracycline regimen chemotherapy: insight from a single centre study
BMC Cardiovascular Disorders
A single-centre retrospective study with prospective cardiac monitoring showing a high incidence of asymptomatic cardiotoxicity using contemporary biomarkers and strain imaging, but limited by retrospective design and lack of a control comparator.
Reported
CTRCD incidence74.5%
Asymptomatic CTRCD (mild)63.26%
Symptomatic CTRCD7.14%